Naurex, Inc.
Industry
- Biotechnology
- Large Molecule
- Drug Discovery Technologies
- Pharmaceuticals
Latest on Naurex, Inc.
Sage Therapeutics, Inc. already is on shaky ground with investors after Zurzuvae (zuranolone) was approved in the US last year for postpartum depression, but not for the larger indication of major de
Venture capital investment dropped about 41% for biopharma firms for the third quarter from Q2, with 94 companies raising $4.5bn in Q3, down from 251 companies that raised $7.6bn in Q2, according to t
The unexpected announcement on 25 June that Allergan PLC will be acquired by AbbVie Inc. for $63bn far exceeded expectations that Allergan would appease its investors by splitting the company in t
Allergan PLC ’s management team survived a shareholder vote driven by activist investors on 1 May, but chairman and CEO Brent Saunders’ statement that the message has been received was followed with v